SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017648
Filing Date
2019-05-09
Accepted
2019-05-09 10:14:29
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20190331.htm 10-Q 1433873
2 EX-31.1 elox-ex311_8.htm EX-31.1 8604
3 EX-31.2 elox-ex312_9.htm EX-31.2 9061
4 EX-32.1 elox-ex321_7.htm EX-32.1 6841
5 EX-32.2 elox-ex322_6.htm EX-32.2 6678
  Complete submission text file 0001564590-19-017648.txt   5969435

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elox-20190331.xml EX-101.INS 1376108
7 XBRL TAXONOMY EXTENSION SCHEMA elox-20190331.xsd EX-101.SCH 51348
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20190331_cal.xml EX-101.CAL 59857
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20190331_def.xml EX-101.DEF 100460
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20190331_lab.xml EX-101.LAB 371323
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20190331_pre.xml EX-101.PRE 268697
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 19809188
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services